Table 3.
Unadjusted and STS adjusted model evaluating preoperative Gal-3 measurements and association with KDIGO stage severity
| KDIGO Stage 1 | KDIGO Stage 2 or 3 | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p value | OR | 95% CI | p value | |
| Unadjusted | ||||||
| Preoperative | 1.03 | 1.01–1.04 | 0.000 | 1.04 | 1.02–1.06 | 0.000 |
| Natural log | 1.47 | 1.19–1.81 | 0.000 | 2.03 | 1.40–2.94 | 0.000 |
| Tertiles | ||||||
| 1 | 1.00 | 1.00–1.00 | 1.00 | 1.00–1.00 | ||
| 2 | 1.12 | 0.83–1.50 | 0.456 | 1.36 | 0.74–2.52 | 0.322 |
| 3 | 1.70 | 1.28–2.27 | 0.000 | 2.86 | 1.63–5.01 | 0.000 |
| Preoperative above median | 1.36 | 1.08–1.72 | 0.009 | 2.44 | 1.53–3.89 | 0.000 |
| STS Readmission Prediction Modela | ||||||
| Preoperative | 1.03 | 1.01–1.04 | 0.002 | 1.03 | 1.00–1.06 | 0.005 |
| Natural log | 1.40 | 1.10–1.78 | 0.006 | 1.87 | 1.23–2.86 | 0.004 |
| Tertiles | ||||||
| 1 | 1.00 | 1.00–1.00 | 1.00 | 1.00–1.00 | ||
| 2 | 1.08 | 0.79–1.48 | 0.625 | 1.37 | 0.73–2.56 | 0.329 |
| 3 | 1.71 | 1.24–2.37 | 0.001 | 2.95 | 1.63–5.34 | 0.000 |
| Preoperative above median | 1.30 | 1.00–1.68 | 0.046 | 2.31 | 1.39–3.85 | 0.001 |
| STS Readmission Prediction Model + NT-pro BNP | ||||||
| Preoperative | 1.02 | 1.01–1.04 | 0.005 | 1.03 | 1.00–1.06 | 0.007 |
| Natural log | 1.31 | 1.03–1.68 | 0.028 | 1.73 | 1.13–2.65 | 0.012 |
| Tertiles | ||||||
| 1 | 1.00 | 1.00–1.00 | 1.00 | 1.00–1.00 | ||
| 2 | 1.08 | 0.79–1.48 | 0.631 | 1.36 | 0.72–2.57 | 0.337 |
| 3 | 1.65 | 1.19–2.29 | 0.003 | 2.85 | 1.57–5.16 | 0.001 |
| Preoperative above median | 1.28 | 0.99–1.66 | 0.060 | 2.26 | 1.35–3.76 | 0.002 |
aModel adjusts for variables included in the STS readmission prediction model
KDIGO Kidney Disease: Improving Global Outcomes, CI confidence interval, OR odds ratio, STS Society of Thoracic Surgeons